Clever Leaves Holdings Inc.

CLVR

CA1867602031

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 20:30:16 31/05/2024 BST			5-day change	1st Jan Change
3.2 ^USD	-1.54%		+6.67%	+52.78%

05-21	Clever Leaves Holdings Inc.(NasdaqCM:CLVR) dropped from S&P TMI Index	CI
05-16	Sector Update: Health Care Stocks Mixed in Late Afternoon Trading	MT

Kyle Detwiler to Step Down from the Position Chairman of the Board of Clever Leaves Holdings Inc., Effective March 24, 2022

February 09, 2022 at 01:04 pm

On February 8, 2022, the Board of Directors of Clever Leaves Holdings Inc. (the “Board”) and Kyle Detwiler mutually determined that Mr. Detwiler would step down from his positions as the Company's Chairman of the Board effective as of March 24, 2022.

Latest news about Clever Leaves Holdings Inc.

Clever Leaves Holdings Inc.(NasdaqCM:CLVR) dropped from S&P TMI Index	05-20	CI
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading	05-16	MT
Sector Update: Health Care	05-16	MT
Clever Leaves Shares Rise as Brazil Investment Fund Acquires 8.5% Stake Before Nasdaq Delisting	05-16	MT
Clever Leaves Holdings Inc.(NasdaqCM:CLVR) dropped from NASDAQ Composite Index	05-15	CI
Top Midday Decliners	04-29	MT
North American Morning Briefing : Investors Brace for This Week's Earnings, Fed Decision	04-29	DJ
Clever Leaves to Delist Securities From Nasdaq	04-26	MT
Clever Leaves Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
Clever Leaves Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	04-01	CI
Earnings Flash (CLVR) CLEVER LEAVES Reports Q4 Revenue $4.6M	04-01	MT
An unknown buyer acquired Portuguese farm assets of Clever Leaves Holdings Inc. for $1.5 million.	03-31	CI
KAC Investments LLC acquired Herbal Brands, Inc. from Clever Leaves Holdings Inc. for $8 million.	03-26	CI
Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia	02-13	CI
Transcript : Clever Leaves Holdings Inc., Q3 2023 Earnings Call, Nov 09, 2023	11-09
Earnings Flash (CLVR) CLEVER LEAVES Reports Q3 Revenue $3.8M, vs. Street Est of $5.2M	11-09	MT
Clever Leaves Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Clever Leaves Holdings Inc. Revises Revenue Guidance for the Full Year 2023	11-09	CI
Transcript : Clever Leaves Holdings Inc., Q2 2023 Earnings Call, Aug 14, 2023	14/08/23
Earnings Flash (CLVR) CLEVER LEAVES Reports Q2 Revenue $5M, vs. Street Est of $5M	14/08/23	MT
Clever Leaves Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Clever Leaves Holdings Inc. Reiterates Earnings Guidance for the Year 2023	14/08/23	CI
Clever Leaf Holdings Inc. Announces Colombian Flower Is Now Available to Australian Patients Through Strategic Partnership with Australian Natural Therapeutics Group	26/07/23	CI
Clever Leaves Holdings Inc.(NasdaqCM:CLVR) dropped from Russell 3000E Value Index	23/06/23	CI
Clever Leaves Holdings Inc.(NasdaqCM:CLVR) dropped from Russell 3000E Index	23/06/23	CI

Chart Clever Leaves Holdings Inc.

Duration

Period

More charts

Company Profile

Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The Company's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. It offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.

Sector

Pharmaceuticals

Calendar

07/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
CLEVER LEAVES HOLDINGS INC.	+52.78%	5.62M
DONG-E-E-JIAO CO.,LTD.	+37.29%	6.02B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-21.28%	4.19B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+4.52%	3.25B
TASLY PHARMACEUTICAL GROUP CO., LTD	-18.16%	2.87B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-7.70%	2.37B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+41.50%	1.89B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.05%	1.58B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-15.56%	1.54B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.62%	1.5B

Alternative Medicine

Clever Leaves Holdings Inc.

Equities

CLVR

CA1867602031

Pharmaceuticals

Kyle Detwiler to Step Down from the Position Chairman of the Board of Clever Leaves Holdings Inc., Effective March 24, 2022

Latest news about Clever Leaves Holdings Inc.

Chart Clever Leaves Holdings Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Alternative Medicine